Abingworth LLP 13D/13G Filings for Soleno Therapeutics, Inc. (SLNO)

Abingworth LLP 13D and 13G filings for Soleno Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-04-08
4:35 pm
Purchase		 2022-03-29 13D Soleno Therapeutics, Inc.
SLNO		 Abingworth LLP 1,224,558
15.300%		 521,598increase
(+74.20%)		 Filing
2020-07-06
4:00 pm
Purchase		 2020-06-26 13D Soleno Therapeutics, Inc.
SLNO		 Abingworth LLP 702,960
13.200%		 376,055increase
(+115.04%)		 Filing